Clinical Trial Update: UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update in multiple myeloma evaluating anti-angiogenesis with thalidomide plus post-transplant consolidation chemotherapy; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-09-22